Clinical trial
Effects of Different Doses of Ticagrelor and Standard-dose Clopidogrel on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease
NCT02889549 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Different Doses of Ticagrelor and Standard-dose Clopidogrel on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- Not reported
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.